Validation of a Cognitive Remediation Program for Bipolar Disorders
NCT02698696, Not applicable, Unknown, Centre hospitalier de Ville-Evrard, France
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Validation of a Cognitive Remediation Program for Bipolar Disorders | ClinicalTrials.gov |
| NCT number | NCT02698696 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 60 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Centre hospitalier de Ville-Evrard, France | ClinicalTrials.gov |
| Conditions | Bipolar Disorder | ClinicalTrials.gov |
| Interventions | ECo program, CRT program, Supportive psychotherapy | ClinicalTrials.gov |
| First posted | 2016-03-04 | ClinicalTrials.gov |
| Last updated | 2024-02-08 | ClinicalTrials.gov |
Registered outcomes 20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Change from baseline Perceptual Reasoning Index at 3 months | baseline and 3 months | Composite score of the Wechsler Adult Intelligence Scale - fourth edition | ClinicalTrials.gov |
| Primary | Change from 3-months Perceptual Reasoning Index at 9 months | 3 months and 9 months | Composite score of the Wechsler Adult Intelligence Scale - fourth edition | ClinicalTrials.gov |
| Secondary | Working Memory Index | baseline, 3 months and 9 months | Composite score of the Wechsler Adult Intelligence Scale - fourth edition | ClinicalTrials.gov |
| Secondary | Processing Speed Index | baseline, 3 months and 9 months | Composite score of the Wechsler Adult Intelligence Scale - fourth edition | ClinicalTrials.gov |
| Secondary | Rey Auditory Verbal Learning Test | baseline, 3 months and 9 months | Neuropsychological test assessing verbal memory | ClinicalTrials.gov |
| Secondary | Cardebat's Verbal Fluencies | baseline, 3 months and 9 months | Neuropsychological test | ClinicalTrials.gov |
| Secondary | Emotion Hexagon | baseline, 3 months and 9 months | Task from the Facial Expressions of Emotion: Stimuli and Tests scale, assessing the recognition of emotions on faces | ClinicalTrials.gov |
| Secondary | Key Search Test | baseline, 3 months and 9 months | Task from the Behavioral Assessment of the Dysexecutive Syndrome scale, assessing planing abilities | ClinicalTrials.gov |
| Secondary | Stroop Color Word Test | baseline, 3 months and 9 months | Neuropsychological test assessing inhibition abilities | ClinicalTrials.gov |
| Secondary | Hamilton Depression Rating Scale | 15 days before baseline, 3 months and 9 months | ClinicalTrials.gov | |
| Secondary | Young Mania Rating Scale | 15 days before baseline, 3 months and 9 months | ClinicalTrials.gov | |
| Secondary | Functional Repercussions Scale | baseline, 3 months and 9 months | Self-assessment scale evaluating the consequences of cognitive impairments in daily life | ClinicalTrials.gov |
| Secondary | Social Desirability Scale | baseline, 3 months and 9 months | Self-assessment scale | ClinicalTrials.gov |
| Secondary | Social Relationships Scale | baseline, 3 months and 9 months | Self-assessment scale | ClinicalTrials.gov |
| Secondary | Self-Appraisal of Illness Questionnaire | baseline, 3 months and 9 months | Self-assessment scale | ClinicalTrials.gov |
| Secondary | Rorschach Inkblot Test | baseline, 3 months and 9 months | ClinicalTrials.gov | |
| Secondary | Change from baseline Event-Related Potentials [ERP] P300 at 3 months during an Oddball task | baseline and 3 months | Assessed for the first third of included patients | ClinicalTrials.gov |
| Secondary | Change from baseline Event-Related Potentials [ERP] N2/P3 complex at 3 months during an emotional Stroop task | baseline and 3 months | Assessed for the first third of included patients | ClinicalTrials.gov |
| Secondary | Change from baseline serum Brain-Derived Neurotrophic Factor [BDNF] level (ng/mL) at 3 months | baseline and 3 months | Assessed for the second third of included patients | ClinicalTrials.gov |
| Secondary | Change from baseline functional Magnetic Resonance Imaging frontal activation at 3 months during an emotion recognition task | baseline and 3 months | Assessed for the last third of included patients | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 3
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 5
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Emoji Emotion Recognition | Secondary outcome | ConductCognition |
| Emotional Stroop Task | Secondary outcome | ConductCognition |
| Oddball Target Detection | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Verbal Learning | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)